Aperio Group LLC lifted its stake in LifePoint Health Inc (NASDAQ:LPNT) by 59.2% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 72,315 shares of the company’s stock after buying an additional 26,892 shares during the period. Aperio Group LLC owned approximately 0.19% of LifePoint Health worth $3,399,000 at the end of the most recent quarter.
A number of other institutional investors have also modified their holdings of LPNT. State of Alaska Department of Revenue acquired a new stake in shares of LifePoint Health in the fourth quarter valued at about $134,000. US Bancorp DE lifted its stake in shares of LifePoint Health by 62.4% in the fourth quarter. US Bancorp DE now owns 3,095 shares of the company’s stock valued at $155,000 after purchasing an additional 1,189 shares during the period. Xact Kapitalforvaltning AB acquired a new stake in shares of LifePoint Health in the fourth quarter valued at about $230,000. Stone Ridge Asset Management LLC acquired a new stake in shares of LifePoint Health in the fourth quarter valued at about $326,000. Finally, Jane Street Group LLC acquired a new stake in shares of LifePoint Health in the fourth quarter valued at about $335,000.
Several analysts recently commented on the stock. BidaskClub upgraded shares of LifePoint Health from a “buy” rating to a “strong-buy” rating in a research report on Friday, May 4th. ValuEngine cut shares of LifePoint Health from a “sell” rating to a “strong sell” rating in a research report on Thursday. SunTrust Banks reiterated a “hold” rating and set a $58.00 price target on shares of LifePoint Health in a report on Monday, May 7th. Raymond James upgraded shares of LifePoint Health from a “market perform” rating to an “outperform” rating and set a $57.00 price target for the company in a report on Thursday, March 15th. Finally, Royal Bank of Canada lowered their price target on shares of LifePoint Health to $58.00 and set an “outperform” rating for the company in a report on Monday, February 26th. Two investment analysts have rated the stock with a sell rating, eleven have assigned a hold rating, six have given a buy rating and one has given a strong buy rating to the stock. LifePoint Health has a consensus rating of “Hold” and a consensus price target of $54.87.
LifePoint Health (NASDAQ:LPNT) last posted its earnings results on Friday, May 4th. The company reported $1.22 EPS for the quarter, topping analysts’ consensus estimates of $1.13 by $0.09. The business had revenue of $1.60 billion for the quarter, compared to analysts’ expectations of $1.62 billion. LifePoint Health had a net margin of 0.48% and a return on equity of 6.56%. The business’s revenue for the quarter was down 1.7% compared to the same quarter last year. During the same period in the previous year, the company posted $1.07 earnings per share. research analysts anticipate that LifePoint Health Inc will post 4.3 earnings per share for the current year.
LifePoint Health Company Profile
LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers, and post-acute facilities in the United States. Its hospitals provide a range of medical and surgical services, such as general surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care, rehabilitation, and pediatric, as well as specialized services, including open-heart surgery, skilled nursing, psychiatric care, and neuro-surgery.
Receive News & Ratings for LifePoint Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health and related companies with MarketBeat.com's FREE daily email newsletter.